The global viscosupplementation market was valued at USD 2.75 billion in 2023 and is expected to grow from USD 2.90 billion in 2024 to USD 4.60 billion by 2032, reflecting a CAGR of 5.9% over the forecast period. In 2023, North America led the market, holding a dominant share of 45.45%.
Viscosupplementation is a medical procedure that involves injecting hyaluronic acid into diarthrodial joints, including the knee, hip, shoulder, and elbow. This treatment helps restore the rheological properties of synovial fluid, providing pain relief, reducing inflammation, and offering chondroprotective benefits.
Request a Free Sample PDF Brochure : https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/viscosupplementation-market-110550
The global viscosupplementation market is experiencing significant growth, driven by advancements in osteoarthritis treatment and an increasing demand for minimally invasive procedures. This article delves into the key industry developments, market drivers and restraints, competitive landscape, market segments, regional insights, and future market scope.
In November 2024, the 4th Annual Conference on Orthopedics, Rheumatology, and Musculoskeletal Disorders was held in Bangkok, Thailand. This conference provided a platform for healthcare professionals to gain knowledge in these fields. One of the key topics discussed was osteoarthritis treatment with hyaluronic acid-based injections, highlighting the growing interest and investment in viscosupplementation therapies.